Related content

Pharmacological basis for functional selectivity of partial muscarinic receptor agonists

By Heldman E.   Barg J.   Fisher A.   Levy R.   Pittel Z.   Zimlichman R.   Kushnir M.   Vogel Z.  

European Journal of Pharmacology, Vol. 297, Iss. 3, 1996-02 ,pp. : 283-291

Elsevier

Access to resources Recommend Favorite

Pharmacological evidence of muscarinic-cholinergic sensitization following chronic stress

By Orsini Cristina   Castellano Claudio   Cabib Simona  

Psychopharmacology, Vol. 155, Iss. 2, 2001-05 ,pp. : 144-147

Springer Publishing Company

Access to resources Recommend Favorite

Muscarinic receptor subtypes in the human colon: lack of evidence for atypical subtypes

By Mansfield K.J.   Mitchelson F.J.   Moore K.H.   Burcher E.  

European Journal of Pharmacology, Vol. 482, Iss. 1, 2003-12 ,pp. : 101-109

Elsevier

Access to resources Recommend Favorite

Synthesis and Pharmacological Profile of a Series of 1-substituted-2-Carbonyl Derivatives of Diphenidol: Novel M4 Muscarinic Receptor Antagonists

By  

Medicinal Chemistry, Vol. 4, Iss. 2, 2008-03 ,pp. : 121-128

Bentham Science Publishers

Access to resources Recommend Favorite

A novel muscarinic M 4 receptor antagonist provides further evidence of an autoreceptor role for the muscarinic M 2 receptor sub-type

By Kitaichi K.   Day J.C.   Quirion R.  

European Journal of Pharmacology, Vol. 383, Iss. 1, 1999-10 ,pp. : 53-56

Elsevier

Access to resources Recommend Favorite